首页>投融资
Ashvattha Therapeutics
B轮
Ashvattha Therapeutics LLC is a pharmaceutical company that creates products that selectively target and treat human diseases.In April 2022, Ashvattha Therapeutics entered an exclusive licensing deal with Huadong Medicine to support the advancement of Ashvattha’s pipeline of hydroxyl dendrimer therapeutics (HDTs), including multiple clinical-stage programs.In April 2022, Ashvattha Therapeutics secured $69 million in a Series B financing round led by Huadong Medicine Investment Holding Co., Ltd
基本信息
-
公司全称Ashvattha Therapeutics Inc
-
类型羟基树枝状聚合物疗法研发商
-
产业领域医药研发/制造
-
公司人数15~50人
-
地址1235 Radio Road Suite 200 REDWOOD CITY CALIFORNIA 94065; US; Telephone: +16508685853;
-
联系电话650-868-5853
-
邮箱info@ashvatthatherapeutics.com
-
成立时间2015-01-01
投融资
-
2025-01-13B轮5000万美元Natural CapitalTribe Capital
-
2022-04-27B轮6900万美元Plum Alley InvestmentsNatural Capital Investment Fund华东医药投资Tribe Capital
-
2021-10-19PreB轮未透露未透露
-
2019-03-15A轮700万美元Kingsley AdvaniNatural Capital
- 加载更多
相关投融资企业
未公开
Aragen Life Sciences is a Contract Research Organization specialized in the discovery, development, and manufacturing of solutions for life sciences companies.In December 2021, Aragen Life Sciences Pvt Ltd had signed a definitive agreement to acquire Pune-based Intox Pvt Ltd
B轮
Ashvattha Therapeutics LLC is a pharmaceutical company that creates products that selectively target and treat human diseases.In April 2022, Ashvattha Therapeutics entered an exclusive licensing deal with Huadong Medicine to support the advancement of Ashvattha’s pipeline of hydroxyl dendrimer therapeutics (HDTs), including multiple clinical-stage programs.In April 2022, Ashvattha Therapeutics secured $69 million in a Series B financing round led by Huadong Medicine Investment Holding Co., Ltd
上市
吉林正业生物制品股份有限公司是一家专业从事兽用生物制品研发、生产、销售及服务的高新技术企业，主要产品包括畜用疫苗和禽用疫苗。目前，公司已拥有畜用、禽用等疫苗49个兽药产品批准文号，7项新兽药证书（包括4个二类和3个三类），产品销往全国三十多个省市和自治区。是全国首批猪蓝耳病灭活疫苗国家定点生产企业、全国拥有“猪胃腹轮三联苗”新兽药证书的三家企业之一，公司的禽霍乱B26-T1200活疫苗和鸡传染性法氏囊病中等毒力活疫苗曾获“国家重点新产品”称号。近年来，公司先后被认定为“农业产业化国家重点龙头企业”、“吉林市战略性新兴产业企业”、“高新技术企业”。
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息